These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 17327410
1. beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Meyer L, Deau B, Forejtníková H, Duménil D, Margottin-Goguet F, Lacombe C, Mayeux P, Verdier F. Blood; 2007 Jun 15; 109(12):5215-22. PubMed ID: 17327410 [Abstract] [Full Text] [Related]
2. Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Walrafen P, Verdier F, Kadri Z, Chrétien S, Lacombe C, Mayeux P. Blood; 2005 Jan 15; 105(2):600-8. PubMed ID: 15358619 [Abstract] [Full Text] [Related]
3. Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis. Bulut GB, Sulahian R, Yao H, Huang LJ. Blood; 2013 Dec 05; 122(24):3964-72. PubMed ID: 24113870 [Abstract] [Full Text] [Related]
4. beta-TrCP mediates the signal-induced ubiquitination of IkappaBbeta. Wu C, Ghosh S. J Biol Chem; 1999 Oct 15; 274(42):29591-4. PubMed ID: 10514424 [Abstract] [Full Text] [Related]
5. Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases. Kanemori Y, Uto K, Sagata N. Proc Natl Acad Sci U S A; 2005 May 03; 102(18):6279-84. PubMed ID: 15845771 [Abstract] [Full Text] [Related]
6. Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. Ray D, Terao Y, Nimbalkar D, Chu LH, Donzelli M, Tsutsui T, Zou X, Ghosh AK, Varga J, Draetta GF, Kiyokawa H. Mol Cell Biol; 2005 Apr 03; 25(8):3338-47. PubMed ID: 15798217 [Abstract] [Full Text] [Related]
13. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Bouscary D, Pene F, Claessens YE, Muller O, Chrétien S, Fontenay-Roupie M, Gisselbrecht S, Mayeux P, Lacombe C. Blood; 2003 May 01; 101(9):3436-43. PubMed ID: 12506011 [Abstract] [Full Text] [Related]
14. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain. Arcasoy MO, Karayal AF. Biochim Biophys Acta; 2005 Apr 15; 1740(1):17-28. PubMed ID: 15878737 [Abstract] [Full Text] [Related]
15. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Yaron A, Hatzubai A, Davis M, Lavon I, Amit S, Manning AM, Andersen JS, Mann M, Mercurio F, Ben-Neriah Y. Nature; 1998 Dec 10; 396(6711):590-4. PubMed ID: 9859996 [Abstract] [Full Text] [Related]
18. Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase. Amir RE, Haecker H, Karin M, Ciechanover A. Oncogene; 2004 Apr 01; 23(14):2540-7. PubMed ID: 14676825 [Abstract] [Full Text] [Related]